Health Canada sticks with Evusheld despite U.S. FDA dropping the COVID drug
While Health Canada says it is "aware" of the U.S. decision to withdraw the emergency use of Evusheld, a drug by AstraZeneca used to help prevent COVID-19 infection--- the agency is maintaining its approval, citing the differences in variant circulation between Canada and the U.S.
The U.S. Food and Drug Administration (FDA) announced on Jan. 26 that its emergency use authorization of the drug was pulled due to its inefficacy in treating “certain” COVID-19 variants.
The FDA stated in a release on its website that as the XBB.1.5. variant, nicknamed “Kraken”, is making up the majority of cases in the country, the use of Evusheld is “not expected to provide protection” and therefore not worth exposing the public to possible side effects of the drug, like allergic reactions.
In an email to CTVNews.ca, Health Canada said the U.S. Food and Drug Administration pulled the drug as the main variant of concern in the U.S. is XBB.1.5.
"Dominant variants in the [U.S.] may be different from those circulating in Canada," the federal agency said in an email. "The most recent epidemiological data in Canada (as of January 1, 2023) indicate that BA.5 (Omicron) subvariants continue to account for more than 89 per cent of reported cases."
On Jan. 6 the FDA said in press release that certain variants are not neutralized by Evusheld and cautioned people who are exposed to XBB.1.5. On Jan. 26, the FDA then updated its website by saying it would be limiting the use of Evusheld.
"Evusheld is not currently authorized for use in the U.S. until further notice by the Agency," the FDA website states.
On Jan. 17, Health Canada issued a "risk communication" on Evusheld, explaining how it may not be effective against certain Omicron subvariants when used as a preventative measure or treatment for COVID-19.
"Decisions regarding the use of EVUSHELD should take into consideration what is known about the characteristics of the circulating COVID-19 variants, including geographical prevalence and individual exposure," Health Canada said in an email.
Health Canada says Evusheld does neutralize against Omicron subvariant BA.2, which according to the agency, is the dominant variant in many communities in Canada.
The drug was introduced for prevention measures specifically for people who have weaker immune systems and are unlikely to be protected by a COVID-19 vaccine. It can only be given to people 12 years and older.
"EVUSHELD is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended," the agency's website reads.
Health Canada says no drug, including Evusheld, is a substitute for vaccination.
COVID-19 COVERAGE
CTVNews.ca Top Stories
Upgrading Safe Third Country Agreement about reassuring Canadians: PM Trudeau
Prime Minister Justin Trudeau says he feels it is his role to see the Safe Third Country Agreement upgraded, in order to make sure Canadians can continue to have confidence in Canada's immigration system.

Foreign mothers of Canadian children seek escape from ISIS detention camp
A group of lawyers is racing against the clock to get Canadian children and their foreign-born mothers onto a plane that will soon be dispatched to repatriate detainees from prison camps in northeast Syria.
Han Dong resigns from Liberal caucus amid foreign interference allegations
Han Dong has announced he will be sitting as an independent MP after being the subject of foreign interference allegations.
Parks Canada says new reservation system working well as bookings open in busy Banff
Parks Canada says its new online reservation system to book camping sites and other activities at national parks appears to have worked well during its first week of operations.
Budget 2023 to detail crackdown on 'junk fees' for consumers: federal source
A federal source says the coming budget will detail how the Liberals plan to go after hidden or unexpected consumer fees, following the United States announcing its own crackdown on these charges.
Former prime minister Stephen Harper says Canada needs a 'Conservative renaissance'
Canada needs a 'Conservative renaissance,' former prime minister Stephen Harper said Wednesday, but he cautioned that Pierre Poilievre should wait until an election before telling Canadians how he might run the country.
All the details we know so far about the coronation of King Charles III
The coronation of King Charles III will take place in May, in a ceremony that is expected to be less extravagant, while underscoring a new era for the Royal Family.
Gwyneth Paltrow ski collision trial set for family testimony
Two daughters of a retired optometrist suing Gwyneth Paltrow are expected to testify on Thursday about the lasting effects of their father and Paltrow's 2016 ski collision as the trial takes on an increasingly personal note on the third day of proceedings.
One week later: Rescuers continue search for victims in rubble of Old Montreal fire
It's been one week since a devastating fire tore through a historic building in Old Montreal, killing at least four.